Navigation Links
Inverness Medical Innovations Announces Second Quarter 2008 Results
Date:7/29/2008

s and

Reconciliation to Non-GAAP Adjusted Cash Basis Amounts

(in $000s, except per share amounts)

Three Months Ended June 30, 2008

Non-GAAP

Adjusted

Non-GAAP Cash

GAAP Adjustments Basis (a)

Net revenue $401,127 $- $401,127

Cost of revenue 195,025 (17,225)(b)(c)(d)(e) 177,800

Gross profit 206,102 17,225 223,327

Gross margin 51% 56%

Operating expenses:

Research and development 29,808 (5,313)(b)(c)(d) 24,495

Selling, general and

administrative 172,792 (50,794)(b)(c)(d) 121,998

Total operating expenses 202,600 (56,107) 146,493

Operating income (loss) 3,502 73,332 76,834

Interest and other income

(expense), net (38,646) 6,624 (c) (32,022)

Income tax (benefit) provision (7,698) 23,066 (h) 15,368

Equity earnings of

unconsolidated entities,

net of tax (2,902) 6,199 (b)(c) 3,297

Net (loss) income $(30,348) $63,089 $32,741

Preferred stock dividends $(3,107) $(3,107)

Net (loss) income

available to common

stockholders - basic $(33,455) $29,634

Net (loss) income per

common share

Basic $(0.43) $0.38

Diluted $(0.43)(i)
'/>"/>

SOURCE Inverness Medical Innovations, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related biology technology :

1. Inverness Medical Innovations Agrees to Acquire Panbio Ltd.
2. Inverness - Chemogen Establish Exclusive License for TB Antibodies
3. Inverness Medical Innovations Announces Proposed Public Offering of Common Stock
4. Inverness Medical Innovations Agrees to Acquire ParadigmHealth
5. Inverness Medical Innovations Acquires ParadigmHealth
6. Inverness Medical Innovations to Participate at JP Morgan Healthcare Conference on January 8, 2008
7. Inverness Medical Innovations to Participate at 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference on February 5, 2008
8. Correction to Press Release Dated January 31, 2008: Inverness Medical Innovations to Participate at 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference on February 5, 2008
9. Inverness Medical Innovations Completes Acquisition of BBI Holdings Plc
10. Inverness Medical Innovations Announces Fourth Quarter 2007 Results
11. Inverness Medical Innovations to Participate at Bank of America 2008 Smid Cap Conference on March 26, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... Vermillion, Inc. (Pink Sheets: VRML), ... C. Wallen, Ph.D. Chief Scientific Officer, Senior ... Laboratories, will be joining its board of ... ,, "Bill brings more than 20 ... and biotechnology," said Gail Page, Vermillion Executive ...
(Date:12/14/2009)... -- Boston Scientific Corporation (NYSE: BSX ) ... $2 billion aggregate principal amount of its senior notes ... offering consists of $850 million of 4.50 percent notes ... due January 2020 and $300 million of 7.375 percent ... use the net proceeds for general corporate purposes, including ...
(Date:12/14/2009)... US-based thermoforming company, has completed the delivery of Brookfield Engineering’s ... to a plastic enclosure with a smaller footprint and more ... ... (PRWEB) December 14, 2009 -- ThermoFab, a US-based thermoforming company, ... – helping Brookfield move from sheet metal to a plastic ...
(Date:12/11/2009)... Therapeutics, Inc., a biopharmaceutical company focused on improving ... cardiovascular and muscle disease, today announced the publication ... crucial role in the progression of amyotrophic lateral ... neuromuscular synaptic regeneration in mice. The findings, ... journal Science , reveal miR-206 as a ...
Breaking Biology Technology:Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 2Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 3Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 4Boston Scientific Announces Completion of $2 Billion Senior Notes Offering 2Boston Scientific Announces Completion of $2 Billion Senior Notes Offering 3Thermofab Helps Brookfield Engineering Move To A Compact Custom Plastic Enclosure 2miRagen announces discovery of key microRNA implicated in Lou Gehrig's disease 2
... YORK, March 12 Biotechnology Value Fund, L.P. ("BVF"), today ... of Avigen, Inc. (Nasdaq: AVGN ) urging stockholders ... replace them with BVF,s four new, stockholder-oriented, independent director nominees ... March 27, 2009. BVF, the beneficial owner of approximately ...
... PALO ALTO, Calif., March 12 The Board of Directors ... today that after careful consideration of Astellas Pharma Inc.,s $16.00 ... advisors, it has determined that Astellas, offer undervalues the Company ... Accordingly, the Board of Directors recommends that stockholders not ...
... Challenge Sought Ideas to Encourage Investment and Collaboration in ... 12 InnoCentive, Inc., the global open ... Center for Accelerating Medical Solutions , today announced that ... solutions they submitted to a Challenge that FasterCures ...
Other Biology Technology:Biotechnology Value Fund Urges Stockholders to Remove and Replace Current Board of Avigen, Inc. in an Effort to Protect and Maximize Stockholder Value 2Biotechnology Value Fund Urges Stockholders to Remove and Replace Current Board of Avigen, Inc. in an Effort to Protect and Maximize Stockholder Value 3Biotechnology Value Fund Urges Stockholders to Remove and Replace Current Board of Avigen, Inc. in an Effort to Protect and Maximize Stockholder Value 4Biotechnology Value Fund Urges Stockholders to Remove and Replace Current Board of Avigen, Inc. in an Effort to Protect and Maximize Stockholder Value 5Biotechnology Value Fund Urges Stockholders to Remove and Replace Current Board of Avigen, Inc. in an Effort to Protect and Maximize Stockholder Value 6Biotechnology Value Fund Urges Stockholders to Remove and Replace Current Board of Avigen, Inc. in an Effort to Protect and Maximize Stockholder Value 7Biotechnology Value Fund Urges Stockholders to Remove and Replace Current Board of Avigen, Inc. in an Effort to Protect and Maximize Stockholder Value 8Biotechnology Value Fund Urges Stockholders to Remove and Replace Current Board of Avigen, Inc. in an Effort to Protect and Maximize Stockholder Value 9CV Therapeutics' Board of Directors Rejects Astellas' Tender Offer 2CV Therapeutics' Board of Directors Rejects Astellas' Tender Offer 3FasterCures Rewards Two InnoCentive Solvers for Innovative Ideas to Accelerate Medical Research 2FasterCures Rewards Two InnoCentive Solvers for Innovative Ideas to Accelerate Medical Research 3FasterCures Rewards Two InnoCentive Solvers for Innovative Ideas to Accelerate Medical Research 4FasterCures Rewards Two InnoCentive Solvers for Innovative Ideas to Accelerate Medical Research 5
(Date:12/11/2009)... is a health risk but why do teens become ... evaluation for Faculty of 1000 Biology, Neil Grunberg looks ... , Grunberg describes the study, published by Natividad et ... suggests it "may have implications to help understand why ... increases the level of dopamine in the brain, a ...
(Date:12/11/2009)... lumpsucker and salmon is the best dietary source of Omega ... the University of Almera (UAL). The scientists analysed the eggs, ... these contained high levels of these fatty acids, which are ... been no precise understanding of the nutritional potential of the ... the UAL has now shown that this is one of ...
(Date:12/11/2009)... 000 people from 190 nations are gathered at ... On Thursday about 150 distinguished guests attended an ... Climate: the Essential Climate Variables,. , During the ... that Earth observation satellites play in providing systematic ... climate change research and for managing mitigation and ...
Breaking Biology News(10 mins):Roe of marine animals is best natural source of omega-3 2Space agencies join forces to systematically observe climate variables 2Space agencies join forces to systematically observe climate variables 3Gene Fix in Egg Prevents Inherited Diseases in Monkeys 55432 1Gene Fix in Egg Prevents Inherited Diseases in Monkeys 55432 2Gene Fix in Egg Prevents Inherited Diseases in Monkeys 55432 3Home Delivery Medical Launches New Division For Sleep Centers 55431 1Home Delivery Medical Launches New Division For Sleep Centers 55431 2Home Delivery Medical Launches New Division For Sleep Centers 55431 3Wellmont Health System Awards Contract to MedQuist for Clinical Documentation Services 55426 1Wellmont Health System Awards Contract to MedQuist for Clinical Documentation Services 55426 2Wellmont Health System Awards Contract to MedQuist for Clinical Documentation Services 55426 3
... Hawkins was a 19th-century British artist and naturalist who ... and its pre-human inhabitants. Hawkins drew worldwide attention in ... dinosaur skeleton, Hadrosaurus foulkii , at The Academy ... prepares to remount a cast of Hadrosaurus in November, ...
... Identified, A Potential Metastatic Disease Target? , Researchers ... of cancer stem cell that might initiate metastatic cancer, ... to other locations within the body. For the first ... these cancer stem cells are much different than those ...
... with autism evaluate facial expressions differently than the rest ... strikingly similar to autistic patients themselves, according to new ... of North Carolina at Chapel Hill and neuroscientist Ralph ... , Piven, Adolphs and colleague Michael Spezio, Ph.D., formerly ...
Other Biology News:Academy publishes first biography of artist-naturalist Benjamin Waterhouse Hawkins 2Academy publishes first biography of artist-naturalist Benjamin Waterhouse Hawkins 3Weill Cornell science briefs June/July 2008 2Weill Cornell science briefs June/July 2008 3Weill Cornell science briefs June/July 2008 4Weill Cornell science briefs June/July 2008 5Weill Cornell science briefs June/July 2008 6Weill Cornell science briefs June/July 2008 7UNC, Caltech research finds further evidence for genetic contribution to autism 2UNC, Caltech research finds further evidence for genetic contribution to autism 3
RABBIT ANTI HUMAN TRRAP (CT) Immunogen: Recombinant C-terminal kinase-related domain of human TRRAP....
...
SHEEP ANTI DEHYDROEPIANDROSTERONE...
... Edited by N.C. Price ... detailed information on protein chemistry ... characterization of proteins. Data on ... Chromatography, crystalization, size determination, amino ...
Biology Products: